Search

everythinglearnresearchcommunity

for

Search:↓

The main enzyme found in pubic skin that could be targeted to treat excessive hair growth is 5 alpha-R2.

Minoxidil, originally a blood pressure medication, is effective in treating hair loss in men and women, with different strengths recommended for each.

Women with acne have lower levels of a specific hormone marker than women without acne.

Bioengineering can potentially treat hair loss by regenerating hair follicles and cloning hair, but the process is complex and needs more research.

Inflammation may be linked to hair loss, and targeting specific enzymes could help treat it.

Finasteride effectively blocks rat enzymes, but with varying methods and strength.

Finasteride inhibits enzyme activity in rhesus macaques, suggesting they're useful for evaluating similar drugs.

Serum biomarkers like insulin-like growth factor-1 and vitamin D may help diagnose androgenetic alopecia.

A new mutation in the Hairless gene causes hair loss in two Pakistani families.

The authors maintain that shorter androgen receptor alleles may lead to milder COVID-19 by positively affecting the immune response, not due to changes in testosterone levels or activity.

G allele of AR Stul polymorphism linked to higher hair loss risk, especially in white people.

Follicular Cell Implantation might become a new treatment for hair loss and could lead to advances in organ regeneration.

Flutamide-induced hypospadias in rats slows down early wound healing.

Phototrichogram helps assess hair loss severity.

Finasteride and minoxidil are effective, low-risk treatments for male hair loss, and patient education on these therapies is important.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

Gender-affirming therapy can cause skin issues like acne and hair loss in transgender adolescents, and more research is needed on its dermatological effects.

Sorafenib helps some advanced cancers alone or with other treatments, but not all, and research continues to improve its use.

δ-GABAA receptors affect alcohol consumption based on the estrous cycle and influence movement regardless of the cycle.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Human hair follicles have a unique metabolism that changes between growth stages and may contribute to baldness.

Spironolactone may cause sexual pain and arousal issues in women, which can improve after stopping the drug and using hormone cream.

Spironolactone harms fish reproduction and is more potent in fish than invertebrates, needing environmental monitoring.

Bald men may have a lower risk of testicular cancer.

Potassium channel openers like minoxidil help hair grow by acting on hair follicles.

Anticancer drugs are increasingly found in surface waters, and their long-term environmental effects are not well understood, requiring better testing methods.

Higher fluoride levels may delay puberty in boys.

Platelet-rich plasma therapy helps increase hair density in male patients with hair loss but doesn't change hair thickness.

A systematic approach is crucial for managing hair loss in women.